PCLUS 6.1-18MN
Go to external page
http://purl.obolibrary.org/obo/NCIT_C2787
A synthetic HIV-1 envelope peptide that was developed for use as a vaccine. Vaccination with PCLUS 6.1-18MN may stimulate the host immune system to mount cytotoxic T lymphocyte (CTL) and T helper cell responses, and induce the production of neutralizing antibodies. (NCI04) [ ]
Term info
Label
PCLUS 6.1-18MN
Synonyms
- AIDs Peptide Vaccine (Peninsula) Construct 6.1-18 MN
- PCLUS 6.1-18MN
Legacy Concept Name
PCLUS_6_1-18MN
NSC Code
663850
Preferred Name
PCLUS 6.1-18MN
Semantic Type
Pharmacologic Substance, Amino Acid, Peptide, or Protein
UMLS CUI
C1518780
code
C2787
Term relations
Subclass of:
- HIV Peptide Vaccine
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Antigen Sensitization
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation